18889881171
Kalkine 0
countryflagUS

Acadia Healthcare Company Inc

Healthcare US ACHC

21.0USD
-0.12(0.57%)

Last update at 2025-06-17T16:45:00Z

Day Range

20.5221.07
LowHigh

52 Week Range

36.5087.77
LowHigh

Fundamentals

  • Previous Close 21.12
  • Market Cap3703.34M
  • Volume230735
  • P/E Ratio13.07
  • Dividend Yield-%
  • EBITDA689.29M
  • Revenue TTM3122.52M
  • Revenue Per Share TTM34.13
  • Gross Profit TTM 1116.77M
  • Diluted EPS TTM3.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -25.36000M 374.14M 275.76M 183.80M 135.99M
Minority interest -5.99900M -6.89400M 4.93M 2.93M 1.20M
Net income -21.66700M 273.14M 190.63M 143.19M 108.92M
Selling general administrative 176.01M 203.47M 175.26M 157.85M 323.21M
Selling and marketing expenses 1618.88M - - - -
Gross profit 682.61M 1116.77M 979.89M 848.17M 1267.22M
Reconciled depreciation 127.11M 117.77M 106.72M 95.26M 164.04M
Ebit 56.77M 443.90M 352.75M 341.90M 404.53M
Ebitda 189.11M 561.67M 459.47M 437.16M 568.58M
Depreciation and amortization 132.35M 117.77M 106.72M 95.26M 164.04M
Non operating income net other - - -24.65000M -7.23300M -
Operating income 506.60M 443.90M 414.47M 365.61M 404.53M
Other operating expenses 2422.14M 2142.70M 1899.92M 1757.14M 2702.93M
Interest expense 82.12M 69.76M 76.99M 158.10M 187.09M
Tax provision -4.98000M 94.11M 67.56M 40.61M 25.87M
Interest income - - - - 187.09M
Net interest income -81.05600M -69.76000M -76.99300M -158.10500M -187.09400M
Extraordinary items - - - - -
Non recurring - - 37.07M 16.47M 81.45M
Other items - - - - -
Income tax expense -9.69900M 94.11M 67.56M 40.61M 25.87M
Total revenue 2928.74M 2610.40M 2314.39M 2089.93M 3107.46M
Total operating expenses 176.01M 649.07M 565.41M 515.38M 862.69M
Cost of revenue 2246.13M 1493.63M 1334.51M 1241.76M 1840.24M
Total other income expense net -531.95600M -72.10100M -120.81400M -148.99000M -268.54400M
Discontinued operations - - -12.64100M -812.39000M -812.39000M
Net income from continuing ops -12.27300M 280.03M 208.20M 143.19M 110.12M
Net income applicable to common shares - 273.14M 190.63M -672.13200M 108.92M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 5358.84M 4987.90M 4768.08M 6499.36M 6879.14M
Intangible assets 73.28M 76.04M 70.14M 68.53M 90.36M
Earning assets - - - - -
Other current assets 61.10M 86.04M 79.89M 61.33M 78.24M
Total liab 2471.18M 2086.92M 2185.20M 4599.91M 4373.76M
Total stockholder equity 2781.97M 2812.73M 2517.49M 1899.46M 2505.38M
Deferred long term liab - - 74.37M 50.02M 140.78M
Other current liab 671.01M 229.24M 233.97M 1012.03M 225.24M
Common stock 0.91M 0.90M 0.89M 0.88M 0.88M
Capital stock 0.91M 0.90M 0.89M 0.88M 0.88M
Retained earnings 131.72M 153.39M -119.75100M -310.38600M 361.75M
Other liab - 206.76M 184.87M 183.43M 225.70M
Good will 2225.96M 2222.80M 2199.94M 2105.26M 2449.13M
Other assets - 95.65M 98.05M 179.27M 71.57M
Cash 100.07M 97.65M 133.81M 378.70M 124.19M
Cash and equivalents - - - - -
Total current liabilities 885.78M 388.33M 404.86M 1308.18M 463.58M
Current deferred revenue 2.17M 6.65M 30.37M 35.95M 38.48M
Net debt 1410.66M 1431.03M 1503.60M 2846.67M 3556.30M
Short term debt 56.48M 47.71M 41.94M 172.39M 72.82M
Short long term debt 29.22M 21.25M 18.59M 153.48M 43.68M
Short long term debt total 1510.73M 1528.68M 1637.41M 3225.37M 3680.49M
Other stockholder equity 2649.34M 2658.44M 2636.35M 2580.33M 2557.64M
Property plant equipment - 2087.28M 1904.92M 1622.90M 3224.03M
Total current assets 596.00M 506.12M 495.03M 2523.39M 542.21M
Long term investments - - - - -
Net tangible assets - 513.88M 247.41M -219.02800M -0.95600M
Short term investments - - - - -
Net receivables 429.53M 322.44M 281.33M 273.55M 339.77M
Long term debt 1342.55M 1364.54M 1478.63M 2968.95M 3105.42M
Inventory 5.30M 5.09M 4.79M 4.85M 4.76M
Accounts payable 156.13M 104.72M 98.58M 87.81M 127.05M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - -371.36500M -414.88400M
Additional paid in capital - - - - -
Common stock total equity - - 0.89M 0.88M 0.88M
Preferred stock total equity - - - - -
Retained earnings total equity - - -119.75100M -310.38600M 361.75M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 43.85M 92.70M 94.97M 79.13M 68.23M
Deferred long term asset charges - - - - 3.34M
Non current assets total 4762.84M 4481.78M 4273.05M 3975.97M 6336.93M
Capital lease obligations 128.07M 142.89M 141.18M 102.94M 538.21M
Long term debt total - - 1478.63M 2968.95M 3105.42M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -379.07100M -305.83000M -84.79500M -281.83900M 105.01M
Change to liabilities - 5.17M 6.16M 136.59M -10.28000M
Total cashflows from investing activities - -305.83000M 1017.63M -281.83900M -201.14100M
Net borrowings - -113.59400M -1640.90400M -44.37100M -52.98400M
Total cash from financing activities -62.69700M -110.90300M -1641.06100M -51.49900M -61.62700M
Change to operating activities - -32.55000M -52.11500M 69.79M 9.66M
Net income -21.66700M 280.03M 195.56M -669.19900M 110.12M
Change in cash 2.42M -36.16400M -244.88400M 254.50M 73.68M
Begin period cash flow 97.65M 133.81M 378.70M 124.19M 50.51M
End period cash flow 100.07M 97.65M 133.81M 378.70M 124.19M
Total cash from operating activities 462.34M 380.57M 374.48M 658.81M 332.90M
Issuance of capital stock - - - 0.18M -
Depreciation 132.35M 117.77M 106.72M 95.26M 164.04M
Other cashflows from investing activities - -7.24800M 1397.97M -24.93000M -21.46700M
Dividends paid - 17.79M 1.59M 1.84M 0.15M
Change to inventory - - -13.98700M 19.31M 6.48M
Change to account receivables -39.01200M -41.97800M 2.45M 15.34M -19.06000M
Sale purchase of stock -52.53200M -17.79200M -5.73400M -1.84300M -1.64900M
Other cashflows from financing activities -46.44700M 2.69M 5.58M -7.31200M 69.58M
Change to netincome - 55.75M 116.56M 1056.99M 77.51M
Capital expenditures 424.13M 296.15M 244.81M 216.62M 284.68M
Change receivables - - 2.45M 15.34M -19.06000M
Cash flows other operating - - -46.93000M 11.19M -1.41700M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - -248.95100M 325.47M 70.14M
Change in working capital 6.63M -69.35400M -43.50300M 163.12M -30.75700M
Stock based compensation 32.29M 29.64M 37.53M 22.50M 17.31M
Other non cash items 406.72M 5.94M 66.40M 994.01M 70.41M
Free cash flow 38.21M 84.42M 129.67M 442.19M 48.22M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ACHC
Acadia Healthcare Company Inc		 -0.12 0.57% 21.00 13.07 11.81 1.19 1.25 1.83 8.99
HCA
HCA Holdings Inc		 2.79 0.76% 371.38 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 -0.42 3.30% 12.29 16.87 9.44 0.42 0.78 0.79 5.37
FSNUF
Fresenius SE & Co. KGaA		 - -% 50.29 16.76 9.62 0.42 0.79 0.78 5.31
JDHIY
JD Health International Inc		 - -% 5.10 62.50 35.97 0.30 2.32 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

Acadia Healthcare Company Inc

6100 Tower Circle, Franklin, TN, United States, 37067

Key Executives

Name Title Year Born
Mr. David M. Duckworth Chief Financial Officer 1980
Mr. John S. Hollinsworth Exec. VP of Operations 1964
Mr. Christopher L. Howard Exec. VP, Gen. Counsel & Sec. 1967
Mr. Laurence L. Harrod Exec. VP of Fin. 1957
Mr. Christopher Howal Hunter CEO & Director 1968
Gretchen Hommrich VP of Investor Relations NA
Mr. Andrew Honeybone Sr. VP & Chief HR Officer NA
Ms. Isa Diaz Sr. VP of Strategic Affairs NA
Dr. Michael Genovese J.D., M.D. Chief Medical Officer NA
Mr. David M. Keys CFA Chief Devel. Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.